Jacobs Levy Equity Management’s Curis CRIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,387
Closed -$948K 958
2022
Q3
$948K Buy
+3,387
New +$1.37M 0.01% 720
2018
Q1
Sell
-226
Closed -$316K 1009
2017
Q4
$316K Buy
226
+160
+242% +$376K 0.01% 839
2017
Q3
$198K Sell
66
-12
-15% -$44.4K ﹤0.01% 865
2017
Q2
$294K Buy
78
+38
+95% +$159K 0.01% 774
2017
Q1
$223K Buy
+40
New +$222K ﹤0.01% 772
2016
Q4
Sell
-17
Closed -$88K 980
2016
Q3
$88K Sell
17
-98
-85% -$359K ﹤0.01% 969
2016
Q2
$358K Buy
115
+38
+49% +$136K 0.01% 845
2016
Q1
$248K Buy
+77
New +$259K 0.01% 923
2014
Q4
Sell
-10
Closed -$28K 836
2014
Q3
$28K Buy
+10
New +$33.6K ﹤0.01% 809

Other funds holding CRIS

Jacobs Levy Equity Management's CRIS Position: Q4 2022 in Review

Jacobs Levy Equity Management sold out of Curis (CRIS) in Q4 2022, closing a stake of 3,387 shares — an estimated $948K sold.

Jacobs Levy Equity Management first reported a position in CRIS in Q3 2014 and held it in 9 quarters. The position peaked at $948K in Q3 2022. 64 funds tracked by Wall St. Rank hold CRIS as of Q4 2022.

  • Jacobs Levy Equity Management reported no remaining Curis position as of Q4 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 3,387 Curis shares in Q4 2022, an estimated $948K.
  • Jacobs Levy Equity Management first reported a position in Curis in Q3 2014 and held it in 9 quarters.
  • Jacobs Levy Equity Management's Curis position peaked at $948K in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Curis as of Q4 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.